Fuzhuan tea consumption imparts hepatoprotective effects and alters intestinal microbiota in high saturated fat diet-fed rats

Molecular Nutrition and Food Research

Volumn 60, Issue 5, 2016, Pages 1213-1220

  Foster, Michelle T ^a   Gentile, Christopher L ^a   Cox York, Kimberly ^a   Wei, Yuren ^a   Wang, Dong ^a   Estrada, Andrea L ^a   Reese, Lauren ^a   Miller, Tirrel ^a   Pagliassotti, Michael J ^a   Weir, Tiffany L ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

Fuzhuan tea; Inflammation; Lactobacillus; Nonalcoholic fatty liver disease; Saturated fat

Indexed keywords

ADIPOCYTOKINE; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; BACTERIAL DNA; ENDOTOXIN; FATTY ACID; LEPTIN; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ANIMAL; BLOOD; CHEMISTRY; DIET THERAPY; FERMENTATION; FOOD HANDLING; INTESTINE; INTESTINE FLORA; ISOLATION AND PURIFICATION; LACTOBACILLUS; LIPID DIET; LIVER; MALE; METABOLISM; MICROBIOLOGY; NONALCOHOLIC FATTY LIVER; RAT; TEA; WISTAR RAT;

ADIPOKINES; ADIPOSE TISSUE; ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ANIMALS; DIET, HIGH-FAT; DNA, BACTERIAL; ENDOTOXINS; FATTY ACIDS; FERMENTATION; FOOD HANDLING; GASTROINTESTINAL MICROBIOME; INTESTINES; LACTOBACILLUS; LEPTIN; LIVER; MALE; NON-ALCOHOLIC FATTY LIVER DISEASE; RATS; RATS, WISTAR; TEA; TRIGLYCERIDES;

EID: 84961267094     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201500654     Document Type: Article

References (38)

1. Fernandez, M. L., Effects of eggs on plasma lipoproteins in healthy populations. Food Func. 2010, 1, 156-160.
2. Mascitelli, L., Pezzetta, F., Diagnosis of nonalcoholic fatty liver disease. J. Am. Med. Assoc. 2003, 290, 1577-1577.
3. Lazo, M., Hernaez, R., Eberhardt, M. S., Bonekamp, S. et al., Prevalence of nonalcoholic fatty liver disease in the united states: the third national health and nutrition examination survey, 1988-1994. Am. J. Epidemiol. 2013, 178, 38-45.
4. Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J. et al., Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J. Clin. Invest. 2005, 115, 1343-1351.
5. Gentile, C. L., Frye, M., Pagliassotti, M. J., Endoplasmic reticulum stress and the unfolded protein response in nonalcoholic fatty liver disease. Antioxid. Redox. Signal. 2011, 15, 505-521.
6. Hotamisligil, G. S., Inflammation and endoplasmic reticulum stress in obesity and diabetes. Int. J. Obes. 2008, 32(Suppl 7), S52-S54.
7. Pagliassotti, M. J., Endoplasmic reticulum stress in nonalcoholic fatty liver disease. Annu. Rev. Nutr. 2012, 32, 17-33.
8. Zhang, X. Q., Xu, X. Q., Yu, C. H., Chen, W. X. et al., Role of endoplasmic reticulum stress in the pathogenesis of nonalcoholic fatty liver disease. World J. Gastroenterol. 2014, 20, 1768-1776.
9. Tanjore, H., Lawson, W. E., Blackwell, T. S., Endoplasmic reticulum stress as a pro-fibrotic stimulus. Biochim. Biophys. Acta 2013, 1832, 940-947.
10. Malhotra, J. D., Kaufman, R. J., Endoplasmic reticulum stress and oxidative stress: a vicious cycle or a double-edged sword? Antioxid. Redox Signal. 2007, 9, 2277-2293.
11. Alisi, A., Ceccarelli, S., Panera, N., Nobili, V., Causative role of gut microbiota in non-alcoholic fatty liver disease pathogenesis. Front. Cell. Infect. Microbiol. 2012, 2, 132.
12. Zhu, L., Baker, S. S., Gill, C., Liu, W. et al., Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH. Hepatology 2013, 57, 601-609.
13. Wang, D., Wei, Y., Pagliassotti, M. J., Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis. Endocrinology 2006, 147, 943-951.
14. Gentile, C. L., Nivala, A. M., Gonzales, J. C., Pfaffenbach, K. T. et al., Experimental evidence for therapeutic potential of taurine in the treatment of nonalcoholic fatty liver disease. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2011, 301, R1710-R1722.
15. Wieckowska, A., McCullough, A. J., Feldstein, A. E., Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future. Hepatology 2007, 46, 582-589.
16. Wu, Y. Y., Ding, L., Xia, H. L., Tu, Y. Y., Analysis of the major chemical compositions in Fuzhuan brick-tea and its effect on activities of pancreatic enzymes in vitro. Afr. J. Biotechnol. 2010, 9, 6748-6754.
17. Keller, A. C., Weir, T. L., Broeckling, C. D., Ryan, E. P., Antibacterial activity and phytochemical profile of fermented Camellia sinensis (fuzhuan tea). Food Res. Int. 2013, 53, 945-949.
18. Ling, T.-J., Wan, X.-C., Ling, W.-W., Zhang, Z.-Z. et al., New triterpenoids and other constituents from a special microbial-fermented tea-fuzhuan brick tea. J. Agri. Food Chem. 2010, 58, 4945-4950.
19. Luo, Z.-M., Du, H.-X., Li, L.-X., An, M.-Q. et al., Fuzhuanins A and B: the B-ring fission lactones of flavan-3-ols from fuzhuan brick-tea. J. Agri. Food Chem. 2013, 61, 6982-6990.
20. Fu, D. Ryan, E. P., Huang, J., Liu, Z. et al., Fermented Camellia sinensis, Fuzhuan Tea, regulates hyperlipidemia and transcription factors involved in lipid catabolism. Food Res. Int. 2011, 44, 2999-3005.
21. Li, Q., Liu, Z., Huang, J., Luo, G. et al., Anti-obesity and hypolipidemic effects of Fuzhuan brick tea water extract in high-fat diet-induced obese rats. J. Sci. Food Agric. 2013, 93, 1310-1316.
22. Liu, Z., Lin, Y., Zhang, S., Wang, D. et al., Comparative proteomic analysis using 2DE-LC-MS/MS reveals the mechanism of Fuzhuan brick tea extract against hepatic fat accumulation in rats with nonalcoholic fatty liver disease. Electrophoresis 2015, 17, 2002-2016.
23. Wang, Y., Xu, A., Liu, P., Li, Z., Effects of Fuzhuan brick-tea water extract on mice infected with E. coli O157:H7. Nutrients 2015, 7, 5309-5326.
24. Xiao, W.-J., Ren, G.-P., Fu, D.-H., Gong, Z.-H. et al., Study on the regulation of blood lipid by Fuzhuan Tea. J. Tea Sci. 2007, 3, 211-214.
25. Kim, D. H., Sandoval, D., Reed, J. A., Matter, E. K. et al., The role of GM-CSF in adipose tissue inflammation. Am. J. Physiol. Endocrinol. Metab. 2008, 295, E1038-E1046.
26. Walter, J., Hertel, C., Tannock, G. W., Lis, C. M. et al., Detection of Lactobacillus, Pediococcus, Leuconostoc, and Weissella species in human feces by using group-specific PCR primers and denaturing gradient gel electrophoresis. Appl. Environ. Microbiol. 2001, 67, 2578-2585.
27. Whelan, J. A., Russell, N. B., Whelan, M. A., A method for the absolute quantification of cDNA using real-time PCR. J. Immunol. Methods 2003, 278, 261-269.
28. Anbarasi, M. S., Ghaayathri, S., Kamaleswari, R., Abirami, I., Outlier detection for multidimensional medical data. Int. J. Comp. Sci. Inform. Technol. 2001, 2, 512-516.
29. Thielecke, F., Boschmann, M., The potential role of green tea catechins in the prevention of the metabolic syndrome-a review. Phytochemistry 2009, 70, 11-24.
30. Bose, M., Lambert, J. D., Ju, J., Reuhl, K. R. et al., The major green tea polyphenol, (-)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice. J. Nutri. 2008, 138, 1677-1683.
31. Lv, X., Chen, Z., Li, J., Zhang, L. et al., Caffeine protects against alcoholic liver injury by attenuating inflammatory response and oxidative stress. Inflamm. Res. 2010, 59, 635-645.
32. Sinha, R. A., Farah, B. L., Singh, B. K., Siddique, M. M. et al., Caffeine stimulates hepatic lipid metabolism by the autophagy-lysosomal pathway in mice. Hepatology 2014, 59, 1366-1380.
33. Apgar, J. L., Shively, C. A., Tarka, S. M., Digestibility of cocoa butter and corn oil and their influence on fatty acid distribution in rats. J. Nutri. 1987, 117, 660-665.
34. Wree, A., Broderick, L., Canbay, A., Hoffman, H. M. et al., From NAFLD to NASH to cirrhosis[mdash]new insights into disease mechanisms. Nat. Rev. Gastroenterol. Hepatol. 2013, 10, 627-636.
35. Lallès, J.-P., Intestinal alkaline phosphatase: multiple biological roles in maintenance of intestinal homeostasis and modulation by diet. Nutri. Rev. 2010, 68, 323-332.
36. Zhang, L., Chow, M. S. S., Zuo, Z., Effect of the co-occurring components from green tea on the intestinal absorption and disposition of green tea polyphenols in Caco-2 monolayer model. J. Pharm. Pharmacol. 2006, 58, 37-44.
37. Oelschlaeger, T. A., Mechanisms of probiotic actions-a review. Int. J. Med. Microbiol. 2010, 300, 57-62.
38. Xin, J., Zeng, D., Wang, H., Ni, X. et al., Preventing non-alcoholic fatty liver disease through Lactobacillus johnsonii BS15 by attenuating inflammation and mitochondrial injury and improving gut environment in obese mice. Appl. Microbiol. Biotechnol. 2014, 98, 6817-6829.